Despite the elevated expression of GAPDH in lung cancer, its manifestation is significantly reduced in ferroptosis scenarios, implying that with the uptick in immune checkpoint protein expression during ferroptosis, tumor cells might navigate immune surveillance more adeptly (59). The gene discussed is GAPDH; the disease is lung carcinoma.